The treatment of the artery high pressure of lung looks forward to _'s treatment

The treatment of the artery high pressure of lung looks forward to _'s treatment
With selecting the constant increase of the therapeutic medicine quantity, the artery high pressure of lung (PAH) for use Treatment prominent to be get already for improvement,last this obviously morbidity and mortality of disease of mortality once. The great majority improve the medicine of the tension of blood vessel such as calcium ion and resist pharmaceuticals short of moneyly, forefront ring plain and analog, inner the intersection of skin and plain receptor resist pharmaceutical and the intersection of phosphoric acid and the intersection of diesterase and 5 inhibitor, already sanction using for the treatment of PAH while being short of money. Newer concept includes using the above-mentioned medicine to jointly treat and pass sGC activator at present ' For instance: BAY63-2521) Wait for compound activate soluble the intersection of urine and the intersection of glucoside and sour ring enzyme activator (sGC) . This kind of sGC activator has already proved that passes with the nitrous oxides (NO) Cooperative effect and resuming in leather function of function,result reconstructed to resist in model at lung artery the clinics of high pressure. Hyperplasia of cell and regulation withering to die have already become a brand-new concept of treating heart and lungs disease at present. Kinase inhibitor such as blood platelet hydroxyphenylaminopropionic acid derives growth factor (PDGF) The receptor resists the pharmaceutical Iraq's mother to take the place of the Buddhist nun (Imatinib) short of moneyly Or many kinase inhibitor Sole is not a Buddhist nun (orafenib) Have already verified that have clinical and the previous curative effect. The other new treatment medicines just found include his spit of fland and rho kinase inhibitor in course of carrying on research at present.
|